Skip to content
buyNotable cluster of 3

Andrew J. Mills bought $75M of MDLN

director at Medline Inc.. 2,586,206 shares at an average of $29.00, traded Dec 18, 2025, filed Dec 22, 2025.

Conviction score
73
Value
$75M
2,586,206 shares
Holdings after
2,586,206
change unknown
From 52-week low
0%
low $39.50, close $39.50
From 52-week high
-4%
high $41.00, as of Dec 18, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $75.0M at market
    +25
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    0% above the 52-week low
    +10
  • Cluster
    3 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +2.7%, 3m +0.7%, 6m -17.7%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

MDLNOct 9, 2026 · close 36.26
Since filing Dec 22, 2025: -14.0%SPY +14.5% · excess -28.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001193125-25-328814, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 16, 2025AGrant or award
Class B Common Stockindirect: See Footnote
+30,655--30,655Dec 22, 2025
Dec 18, 2025POpen-market purchase
Class A Common Stockindirect: See Footnote
+2,586,206$29.00$75M2,586,206Dec 22, 2025
Dec 16, 2025AGrant or award
Common Units of Medline Holdings, LPderivativeindirect: See Footnote
+30,655--30,655Dec 22, 2025

Related signals

Other insiders at Medline Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
57Moderate
MDLNsell
Medline Inc.
GIC Private Ltd
owner
$722M
20,678,630 shares
-91%
37Weak
MDLNsell
Medline Inc.
GIC Private Ltd
owner
$57M
1,600,000 shares
-7%
37Weak
MDLNsell
Medline Inc.
GIC Private Ltd
owner
$21M
590,284 shares
-2%
37Weak
MDLNsell
Medline Inc.
GIC Private Ltd
owner
$80M
2,248,612 shares
-8%
25Weak
MDLNsell10b5-1
Medline Inc.
Douglas P Golwas
Chief Commercial Officer
$3.7M
100,000 shares
-81%
52Moderate
MDLNbuy
Medline Inc.
Jessi L Corcoran
Principal Accounting Officer
$171k
5,000 shares
-
62Notable
MDLNsell 3
Medline Inc.
BCP 8 Holdings Mozart Manager L.L.C.
owner
$1.2B
33,317,824 shares
-30%
62Notable
MDLNsell 3
Medline Inc.
BX Mozart ML-2 Holdco L.P.
owner
$1.2B
33,317,824 shares
-30%
72Notable
MDLNsell 3
Medline Inc.
Hellman & Friedman Capital Partners X (Parallel), L.P.
owner
$1.2B
31,868,237 shares
-175%
57Moderate
MDLNsell 7
Medline Inc.
BCP 8 Holdings Mozart Manager L.L.C.
owner
$1.1B
27,852,986 shares
-22%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Andrew J. Mills bought $75M of MDLN | InsiderTell